| The sympathetic nervous system mitigates CNS autoimmunity via β2-adrenergic receptor signaling in immune cells LP Araujo, JT Maricato, MG Guereschi, MC Takenaka, VM Nascimento, ... Cell reports 28 (12), 3120-3130. e5, 2019 | 57 | 2019 |
| β-Actin-binding complementarity-determining region 2 of variable heavy chain from monoclonal antibody C7 induces apoptosis in several human tumor cells and is protective … DC Arruda, LCP Santos, FM Melo, FV Pereira, CR Figueiredo, AL Matsuo, ... Journal of Biological Chemistry 287 (18), 14912-14922, 2012 | 49 | 2012 |
| Anti‐metastatic immunotherapy based on mucosal administration of flagellin and immunomodulatory P10 FM De Melo, CJM Braga, FV Pereira, JT Maricato, CST Origassa, ... Immunology and cell biology 93 (1), 86-98, 2015 | 38 | 2015 |
| A natural bacterial-derived product, the metalloprotease arazyme, inhibits metastatic murine melanoma by inducing MMP-8 cross-reactive antibodies FV Pereira, CA Ferreira-Guimaraes, T Paschoalin, JAB Scutti, FM Melo, ... PloS one 9 (4), e96141, 2014 | 25 | 2014 |
| Adrenergic signaling regulation of macrophage function: do we understand it yet? BM Freire, FM de Melo, AS Basso Immunotherapy Advances 2 (1), ltac010, 2022 | 15 | 2022 |
| SOCS1 favors the epithelial-mesenchymal transition in melanoma, promotes tumor progression and prevents antitumor immunity by PD-L1 expression R Berzaghi, VSC Maia, FV Pereira, FM Melo, MS Guedes, CST Origassa, ... Scientific reports 7 (1), 40585, 2017 | 14 | 2017 |
| TLR4-mediated immunomodulatory properties of the bacterial metalloprotease arazyme in preclinical tumor models FV Pereira, ACL Melo, FM de Melo, D Mourão-Sá, P Silva, R Berzaghi, ... Oncoimmunology 5 (7), e1178420, 2016 | 12 | 2016 |
| Interleukin-6 and the gut microbiota influence melanoma progression in obese mice FV Pereira, ACL Melo, MB Silva, FM de Melo, FF Terra, IA Castro, ... Nutrition and Cancer 73 (4), 642-651, 2021 | 9 | 2021 |
| Peptide R18H from BRN2 transcription factor POU domain displays antitumor activity in vitro and in vivo and induces apoptosis in B16F10-Nex2 cells FFM da Cunha, KCU Mugnol, FM de Melo, MVSQ Nascimento, ... Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal …, 2019 | 7 | 2019 |
| Immune system modulation by the adjuvants Poly (I: C) and Montanide ISA 720 RF Marques, FM De Melo, JT Novais, IS Soares, DY Bargieri, ... Frontiers in Immunology, 3264, 2022 | 5 | 2022 |
| The transcription factor NF-κB orchestrates nucleosome remodeling during the primary response to Toll-like receptor 4 signaling AC Feng, BJ Thomas, PK Purbey, FM de Melo, X Liu, AE Daly, F Sun, ... Immunity 57 (3), 462-477. e9, 2024 | 3 | 2024 |
| Unraveling the metabolism of Mycobacterium caprae using comparative genomics GE Romano, TT Silva-Pereira, FM de Melo, MC Sisco, AC Banari, ... Tuberculosis 136, 102254, 2022 | 2 | 2022 |
| Quantum-Dot-Based Iron Oxide Nanoparticles Activate the NLRP3 Inflammasome in Murine Bone Marrow-Derived Dendritic Cells FM de Melo, K Kawasaki, TA Sellani, BS Bonifácio, RA Mortara, HE Toma, ... Nanomaterials 12 (18), 3145, 2022 | 1 | 2022 |
| The role of SOCS-1 in stimulating melanoma development through tyrosine-kinase receptors and MAPK pathways and prevents antitumour immunity by PD-L1 expression R Berzaghi, VSC Maia, FV Pereira III, FM De Melo, LR Travassos, ... CANCER IMMUNOLOGY RESEARCH 4 (1), 2016 | | 2016 |
Felipe Valença PereiraResearch Associate, University of Colorado在 cuanschutz.edu 的电子邮件经过验证
